News Flash

  • All
  • Parkway Laboratory
  • Industry
September 30, 2015 Change in Reference Ranges of Immunoglobulins G, A, M for Paediatrics and Children of 18 Years Old & Below
September 29, 2015 Immediate Availability Of Vitamin D (25-Oh Vitamin D) Processing At Mount Elizabeth Novena Hospital; Gleneagles Hospital To Start On 15 October 2015
June 16, 2015 New Assay Defines an Individual’s Total Virus Burden
March 2, 2015 The new Parkway Laboratory Services Guide (10th Edition 2015) is out! (Available under FAQ Section)
January 26, 2015 Change Testing Analyser of Immunoglobulins G, A, M, Complements 3 & 4, Lipoprotein(a), Ceruloplasmin
December 26, 2014 Change of Resulting in Urine Phase Contrast Test (DYS RBC)
November 25, 2014 Change of Testing Method of Anti Mullerian Hormone
September 30, 2015 Change in Reference Ranges of Immunoglobulins G, A, M for Paediatrics and Children of 18 Years Old & Below
September 29, 2015 Immediate Availability Of Vitamin D (25-Oh Vitamin D) Processing At Mount Elizabeth Novena Hospital; Gleneagles Hospital To Start On 15 October 2015
March 2, 2015 The new Parkway Laboratory Services Guide (10th Edition 2015) is out! (Available under FAQ Section)
January 26, 2015 Change Testing Analyser of Immunoglobulins G, A, M, Complements 3 & 4, Lipoprotein(a), Ceruloplasmin
December 26, 2014 Change of Resulting in Urine Phase Contrast Test (DYS RBC)
November 25, 2014 Change of Testing Method of Anti Mullerian Hormone
June 16, 2015 New Assay Defines an Individual’s Total Virus Burden

Latest Tests

Immediate Availability Of Vitamin D (25-Oh Vitamin D) Processing At Mount Elizabeth Novena Hospital; Gleneagles Hospital To Start On 15 October 2015

Major Technological Advancement in Cervical Cancer Screening Now Available in Singapore

ThinPrep Imaging System: First to be offered by Parkway Laboratory Services Ltd

thinprep_imaging_system

Thinprep Imaging System

Singapore, 22 June 2011 – Since the introduction of the conventional Pap smear more than 50 years ago, two key technological advances have raised cervical cancer screening standards to new levels:

The introduction of the ThinPrep Pap Test in 1996 was the world’s first major advance in cervical cancer screening. With this method, cervical cells are rinsed into a liquid and a machine prepares the sample for microscopic review. Representative cervical cells placed on a glass slide in a thin, even layer resulted in improved detection of disease. The ThinPrep Pap Test is the most widely used Pap test in the United States, and Parkway has been offering this technology in Singapore for more than 10 years.

Read More

ParkwayHealth Laboratory offers first-of-its-kind MaterniT21 PLUS™ test for foetal DNA sequencing

Singapore, 9 May 2013 – ParkwayHealth Laboratory, a unit of Parkway Pantai Group and a provider of high-quality clinical laboratory services, now exclusively offers the MaterniT21 PLUS™ test, a novel, cutting-edge, non-invasive, pre-natal test that allows expectant parents to screen, with more than 98.6% accuracy, the likelihood of their child having Down’s Syndrome, Edwards Syndrome, Patau Syndrome and sex-linked syndromes, with the convenience of one simple blood test.

Read More

ParkwayHealth Laboratory first in Singapore to offer fully automated Hepatitis B Surface Antigen (HBsAg) Quantitative Assay

Singapore, 9 July 2013 – ParkwayHealth Laboratory, a unit of Parkway Pantai Group, a provider of high-quality clinical laboratory services, is the first in Singapore to offer the novel Hepatitis B Surface Antigen (HBsAg) Quantitative Assay.

With HBsAg Quantitative Assay, physicians can now receive greater valuable information about the condition of patients afflicted with Hepatitis B and allows better tailoring of treatment and clinical management to the patient. Chronic HBV patients can use the HBsAg Quantitative Assay to monitor their illness, their response to treatment and predict the potential of developing liver cirrhosis (scarring of the liver) and cancer.

Read More